Editas Medicine, Inc. (EDIT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 449.00M |
| Enterprise value | 162.43M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.31 |
| Price/book (mrq) | 1.29 |
| Enterprise value/revenue | 2.08 |
| Enterprise value/EBITDA | -1.00 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.02 |
| 52-week change 3 | -30.89% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 11.91 |
| 52-week low 3 | 5.28 |
| 50-day moving average 3 | 7.69 |
| 200-day moving average 3 | 8.37 |
Share statistics
| Avg vol (3-month) 3 | 1.93M |
| Avg vol (10-day) 3 | 1.8M |
| Shares outstanding 5 | 82.23M |
| Implied shares outstanding 6 | 82.23M |
| Float 8 | 76.15M |
| % held by insiders 1 | 0.32% |
| % held by institutions 1 | 80.15% |
| Shares short (28 Mar 2024) 4 | 16.36M |
| Short ratio (28 Mar 2024) 4 | 6.85 |
| Short % of float (28 Mar 2024) 4 | 28.10% |
| Short % of shares outstanding (28 Mar 2024) 4 | 20.00% |
| Shares short (prior month 29 Feb 2024) 4 | 13.52M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -196.12% |
| Operating margin (ttm) | -39.90% |
Management effectiveness
| Return on assets (ttm) | -20.87% |
| Return on equity (ttm) | -43.17% |
Income statement
| Revenue (ttm) | 78.12M |
| Revenue per share (ttm) | 1.03 |
| Quarterly revenue growth (yoy) | 818.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -163.12M |
| Net income avi to common (ttm) | -153.22M |
| Diluted EPS (ttm) | -2.02 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 323.11M |
| Total cash per share (mrq) | 3.95 |
| Total debt (mrq) | 36.54M |
| Total debt/equity (mrq) | 10.47% |
| Current ratio (mrq) | 5.39 |
| Book value per share (mrq) | 4.27 |
Cash flow statement
| Operating cash flow (ttm) | -132.18M |
| Levered free cash flow (ttm) | -87.81M |
© 2024 Yahoo. All rights reserved.